What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Mono Pharmacare Limited IPO?

Based on the upper price band of ₹28 and current GMP of ₹2, the estimated listing price is ₹30 (approx. 7.1% gain).

What is the expected profit per lot for Mono Pharmacare Limited IPO?

With a lot size of 4000 shares and current GMP of ₹2, expected profit per retail application lot is approximately ₹8,000.

IPO GreyPremiumLIVE

Grey Market Intelligence

Mono Pharmacare Limited

ListedSME

Healthcare · NSE

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

Price Band

₹26 – ₹28

Issue Size

₹14.84 Cr

Lot Size

4000 shares

GMP

₹2

+7.1%

Est. Listing

₹30

at current GMP

Subscribed

13.47x

overall

Open

28 Aug 2023

30 Aug 2023

Allotment

4 Sep 2023

Refund

5 Sep 2023

Demat Credit

6 Sep 2023

Listing

7 Sep 2023

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Mono Pharmacare Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹2+7.1%

Issue Price (Upper)

₹28

Band: ₹26 – ₹28

Estimated Listing Price

₹30

Upper price + GMP

Lot Size

4000 shares

Min investment ₹1,12,000

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹2	7.1%	₹30
30 Oct 2026	+₹2	7.1%	₹30
29 Oct 2026	+₹2	6.4%	₹30

About Mono Pharmacare Limited Public Issue & Market Profile

Mono Pharmacare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹14.84 Crores. The shares are offered at a price band of ₹26 to ₹28 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Public Issue & Pricing Context:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Basis of Allotment & Listing Timeline:

Following the close of bidding on 2023-08-30, the basis of allotment is scheduled to be finalized on 2023-09-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Mono Pharmacare Limited IPO GMP today?

The latest grey market premium for Mono Pharmacare Limited IPO is ₹2, which indicates an expected listing price of ₹30.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.